Steven Lim

Array ( [id] => 4594968 [patent_doc_number] => 07981415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Humanized PAI-1 antibodies' [patent_app_type] => utility [patent_app_number] => 12/274793 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 58006 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 601 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981415.pdf [firstpage_image] =>[orig_patent_app_number] => 12274793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6493448 [patent_doc_number] => 20100209422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA-AMYLOID PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/738955 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18570 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209422.pdf [firstpage_image] =>[orig_patent_app_number] => 12738955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436183 [patent_doc_number] => 20090170770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP 1) INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/265521 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 24592 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170770.pdf [firstpage_image] =>[orig_patent_app_number] => 12265521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007061 [patent_doc_number] => 20110059092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'ANTIBODIES SPECIFIC OF THE BETA-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS' [patent_app_type] => utility [patent_app_number] => 12/740217 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12529 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059092.pdf [firstpage_image] =>[orig_patent_app_number] => 12740217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571206 [patent_doc_number] => 08337848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Monoclonal antibody for APP' [patent_app_type] => utility [patent_app_number] => 12/739599 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7375 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545379 [patent_doc_number] => 20090155256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Immunotherapy Regimes Dependent On APOE Status' [patent_app_type] => utility [patent_app_number] => 12/253929 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 48041 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 71 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155256.pdf [firstpage_image] =>[orig_patent_app_number] => 12253929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234733 [patent_doc_number] => 20100266505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS' [patent_app_type] => utility [patent_app_number] => 12/738396 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 47986 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266505.pdf [firstpage_image] =>[orig_patent_app_number] => 12738396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607648 [patent_doc_number] => 08784810 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Treatment of amyloidogenic diseases' [patent_app_type] => utility [patent_app_number] => 13/123898 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26709 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473025 [patent_doc_number] => 20090246191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/251277 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24668 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246191.pdf [firstpage_image] =>[orig_patent_app_number] => 12251277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261906 [patent_doc_number] => 20100297013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HUMANIZED ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/681683 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 48400 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297013.pdf [firstpage_image] =>[orig_patent_app_number] => 12681683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261896 [patent_doc_number] => 20100297012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'HUMANIZED ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/681673 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 51129 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297012.pdf [firstpage_image] =>[orig_patent_app_number] => 12681673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441366 [patent_doc_number] => 20090093005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'PROTEIN-BASED BIOMARKERS FOR ABDOMINAL AORTIC ANEURYSM' [patent_app_type] => utility [patent_app_number] => 12/245322 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20609 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093005.pdf [firstpage_image] =>[orig_patent_app_number] => 12245322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581568 [patent_doc_number] => 20100291097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/681696 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 58232 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291097.pdf [firstpage_image] =>[orig_patent_app_number] => 12681696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234892 [patent_doc_number] => 20100266596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'THERAPEUTIC ANTIBODY PURIFICATION METHOD AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 12/681050 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5010 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266596.pdf [firstpage_image] =>[orig_patent_app_number] => 12681050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417187 [patent_doc_number] => 20090043074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Use of Ghrelin Splice Variant for Treating Cachexia and/or Anorexia and/or Anorexia-Cachexia and/or Malnutrition and/or Lipodystrophy and/or Muscle Wasting and/or Appetite-Stimulation' [patent_app_type] => utility [patent_app_number] => 12/239229 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38385 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20090043074.pdf [firstpage_image] =>[orig_patent_app_number] => 12239229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527212 [patent_doc_number] => 20090197289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'METHOD FOR CONFIRMING A DIAGNOSIS OF AUTISM' [patent_app_type] => utility [patent_app_number] => 12/238415 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5458 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197289.pdf [firstpage_image] =>[orig_patent_app_number] => 12238415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575932 [patent_doc_number] => 20090143294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'METHODS OF TREATING VASODILATORY SHOCK' [patent_app_type] => utility [patent_app_number] => 12/235062 [patent_app_country] => US [patent_app_date] => 2008-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10089 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143294.pdf [firstpage_image] =>[orig_patent_app_number] => 12235062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580502 [patent_doc_number] => 20090175848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Modulation of the Cooperativity Between the Ion Channels TRPM5 and TRPA1' [patent_app_type] => utility [patent_app_number] => 12/212508 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15106 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175848.pdf [firstpage_image] =>[orig_patent_app_number] => 12212508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8548767 [patent_doc_number] => 08323647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Humanized antibodies against the β-amyloid peptide' [patent_app_type] => utility [patent_app_number] => 12/677732 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 47 [patent_no_of_words] => 9683 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12677732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292535 [patent_doc_number] => 20100239570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'MONCOLONAL AMYLOID BETA (ABETA) - SPECIFIC ANTIBODY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/733523 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12787 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239570.pdf [firstpage_image] =>[orig_patent_app_number] => 12733523 [rel_patent_id] =>[rel_patent_doc_number] =>)